openPR Logo
Press release

Global Leader in Cancer Vaccines: US Continues to Surge on Growth Path

01-24-2013 04:49 PM CET | Health & Medicine

Press release from: RNCOS E-Services Pvt. Ltd.

/ PR Agency: RNCOS E-Services Pvt. Ltd.
US currently holds a 49% share in the global cancer vaccines market and continues to experience robust growth opportunities.

US currently holds a 49% share in the global cancer vaccines market and continues to experience robust growth opportunities.

A new research report from RNCOS shows that the US is in the lead for cancer vaccines and accounts for a robust share of 49% in the global market. The market continues to surge for even greater developments backed by active funding and support by both the government and private players. Both the prophylactic and therapeutic vaccines are in a promising position in the US market. In particular government support has been observed to prophylactic cancer vaccines as a remedy for the high mortality of cervical cancer in females. Therapeutic cancer vaccines holds great promise due to the large number of candidates in clinical trials. On the competitive front, both Merck and GSK are expected to continue to hold a dominant position.

The research and innovation for cancer vaccines is highly robust and several candidates are being studied for their role in cancer with surprisingly large number of trials focused on the therapeutic vaccines. With growing diseases and requirement for specialized drugs and vaccines as a major driver, the share of therapeutic vaccines is expected to grow by 15% in 2012. The current marketed product portfolio includes Merck’s Gardasil, GSK’s Cervarix, and several other Hepatitis B vaccines while the only therapeutic vaccine in the market is Dendreon’s Provenge. In terms of state level market opportunity, California ranks top in the total number of new cancer cases followed by Florida, Texas and New York representing a promising market for cancer vaccines.

The report entitled, “US Cancer Vaccine Market Analysis”, provides an analysis of the market drivers, current market size, and future estimates. It also provides the key constraints faced by these cancer vaccine products that can hinder its market growth in the future. Moreover, an in-depth analysis of all the candidate cancer vaccines in various phases of clinical trials for highly prevalent cancers in the US has been covered to identify opportunities for players. Further, the report provides competitive analysis of the promising players in the market along with their key strategies for business expansion. The regulatory environment detailing the whole cancer vaccine approval process along with FDA’s guidelines to the industry for clinical proceedings of cancer therapeutic vaccines has also been covered in this report.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM457.htm

Some of our Related Reports are:

- Global Vaccine Market Forecast to 2013 (http://www.rncos.com/Report/IM357.htm)
- Global Influenza Vaccine Market Analysis (http://www.rncos.com/Report/IM356.htm)
- Global Vaccine Market Forecast to 2012 (http://www.rncos.com/Report/IM153.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

NONE

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Leader in Cancer Vaccines: US Continues to Surge on Growth Path here

News-ID: 248518 • Views:

More Releases from RNCOS E-Services Pvt. Ltd.

Malaysia Convenience Store Witnessing Tremendous Growth
Malaysia Convenience Store Witnessing Tremendous Growth
“Rapid expansion plans of major convenience stores in Malaysia such as 7-Eleve and 99 Speed Mart are expected to drive the market.” says RNCOS Malaysia Convenience store has been witnessing a tremendous growth in the retail industry. Key players in the country are widening their foot prints in retail industry by innovatively increasing the product portfolio as per the consumer behavior and increasing the number of stores. There is a cut
Growing Opportunity in the Global Enterprise Software Market
Growing Opportunity in the Global Enterprise Software Market
“Increasing adoption of enterprise resource management software, customer relationship management software and human resource management software is expected to drive the Global Enterprise Software market.” Says RNCOS The global enterprise software market has reported a significant growth in the recent years and is presenting ample opportunities to the industry’s players. With increasing global competition and rising awareness regarding enterprises software across the globe, the worldwide enterprise software market is poised to

More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the